These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39298)

  • 1. Interaction of a series of beta-adrenergic blocking drugs with rat hepatic microsomal monooxygenase.
    Facino RM; Lanzani R
    Pharmacol Res Commun; 1979 May; 11(5):433-45. PubMed ID: 39298
    [No Abstract]   [Full Text] [Related]  

  • 2. The inhibitory effect of pyrazinamide on microsomal monooxygenase activities is related to the binding to reduced cytochrome P-450.
    Maffei Facino R; Carini M
    Pharmacol Res Commun; 1980 Jun; 12(6):523-37. PubMed ID: 7403228
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyridine nucleotide involvement in rat hepatic microsomal drug metabolism--I. Factors that influence NADPH kinetic estimations during mixed function oxidase reactions.
    Gourlay GK; Stock BH
    Biochem Pharmacol; 1978 Mar; 27(6):965-8. PubMed ID: 26354
    [No Abstract]   [Full Text] [Related]  

  • 4. NADPH-dependent production of oxy radicals by purified components of the rat liver mixed function oxidase system. II. Role in microsomal oxidation of ethanol.
    Winston GW; Cederbaum AI
    J Biol Chem; 1983 Feb; 258(3):1514-9. PubMed ID: 6296102
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of various types of inducing agents on hepatic microsomal monooxygenase activity in rainbow trout.
    Vodicnik MJ; Elcombe CR; Lech JJ
    Toxicol Appl Pharmacol; 1981 Jun; 59(2):364-74. PubMed ID: 7256774
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of aging and induction of rat liver and kidney microsomal mixed function oxidase systems.
    McMartin DN; O'Connor JA; Fasco MJ; Kaminsky LS
    Toxicol Appl Pharmacol; 1980 Jul; 54(3):411-9. PubMed ID: 7394797
    [No Abstract]   [Full Text] [Related]  

  • 7. A reevaluation of the role of cytochrome P-450 as the terminal oxidase in hepatic microsomal mixed function oxidase catalyzed reactions.
    Cooper DY; Schleyer H; Levin SS; Eisenhardt RH; Novack BG; Rosenthal O
    Drug Metab Rev; 1979; 10(2):153-85. PubMed ID: 399457
    [No Abstract]   [Full Text] [Related]  

  • 8. Developmental aspects of the hepatic cytochrome P450 monooxygenase system.
    Neims AH; Warner M; Loughnan PM; Aranda JV
    Annu Rev Pharmacol Toxicol; 1976; 16():427-45. PubMed ID: 820239
    [No Abstract]   [Full Text] [Related]  

  • 9. On the spectral intermediate at 440 nm formed during mixed function substrate oxidation.
    Illing HP; Kunke S; Netter KJ
    Biochem Pharmacol; 1974 Sep; 23(18):2603-16. PubMed ID: 4153422
    [No Abstract]   [Full Text] [Related]  

  • 10. Constitutive and induced hepatic microsomal cytochrome P-450 monooxygenase activities in male Fischer-344 and CD rats. A comparative study.
    Dent JG; Graichen ME; Schnell S; Lasker J
    Toxicol Appl Pharmacol; 1980 Jan; 52(1):45-53. PubMed ID: 6767296
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of DDT on hepatic microsomal drug-metabolising enzymes in the baboon: comparison with the rat.
    Down WH; Chasseaud LF
    Bull Environ Contam Toxicol; 1978 Nov; 20(5):592-601. PubMed ID: 104750
    [No Abstract]   [Full Text] [Related]  

  • 12. On the possible in vitro use of perfluoro compounds as oxygen reservoir for the microsomal monooxygenase system.
    Brown NA; Netter KJ; Bridges JW
    Biochem Pharmacol; 1979 Sep; 28(18):2850-2. PubMed ID: 115475
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the mechanism of cadmium-induced inhibition of the hepatic microsomal monooxygenase of the male rat.
    Means JR; Carlson GP; Schnell RC
    Toxicol Appl Pharmacol; 1979 Apr; 48(2):293-304. PubMed ID: 473179
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced cytochrome c as an electron donor for microsomal mixed-function oxidase reactions.
    Wahle KW; Davies NT
    Proc Nutr Soc; 1977 May; 36(1):29A. PubMed ID: 19743
    [No Abstract]   [Full Text] [Related]  

  • 15. Activities of hepatic and extrahepatic microsomal mixed function oxidase enzymes in diabetic and gonadectomized-diabetic rats.
    Al-Turk WA; Stohs SJ; Roche EB
    Gen Pharmacol; 1981; 12(5):345-50. PubMed ID: 7286602
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of NADPH oxidation and related drug oxidation in liver microsomes by zinc.
    Chvapil M; Ludwig JC; Sipes IG; Misiorowski RL
    Biochem Pharmacol; 1976 Aug; 25(15):1787-91. PubMed ID: 8050
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of lipophilicity in the inhibition of polymorphic cytochrome P450IID6 oxidation by beta-blocking agents in vitro.
    Ferrari S; Leemann T; Dayer P
    Life Sci; 1991; 48(23):2259-65. PubMed ID: 1675413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of storage on microsomal mixed function oxidase activity in mouse liver.
    Litterst CL; Mimnaugh EG; Reagan RL; Gram TE
    Biochem Pharmacol; 1974 Sep; 23(17):2391-4. PubMed ID: 4139954
    [No Abstract]   [Full Text] [Related]  

  • 19. Mixed type hepatic microsomal enzyme induction by hexachlorobenzene.
    Stonard MD
    Biochem Pharmacol; 1975 Nov; 24(21):1959-63. PubMed ID: 1212246
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of nitrofuran derivatives on hepatic microsomal mixed-function oxidase activity in rats.
    Fukuhara M; Takabatake E
    Toxicol Appl Pharmacol; 1977 Dec; 42(3):571-81. PubMed ID: 601798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.